Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
- Status
- COMPLETED
- Phase
- N/A
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
- Status
- COMPLETED
- Phase
- PHASE1
Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BMS-247550 in Treating Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
PS-341 in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
- Status
- COMPLETED
- Phase
- PHASE3
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2